Literature DB >> 426140

The 24-hour dexamethasone suppression test in a clinical setting: relationship to diagnosis, symptoms, and response to treatment.

W A Brown, R Johnston, D Mayfield.   

Abstract

Of 54 male psychiatric patients undergoing dexamethasone suppression tests in a clinical setting, 40% of those with a major depressive disorder showed escape from suppression over the 24 hours after dexamethasone administration, while all of the patients with schizophrenia, neurosis, alcoholism,and drug abuse showed normal pituitary-adrenal suppression. Only 10% of the depressed patients showed resistance to suppression 8 hours after dexamethasone administration. There was no difference between depressed patients who did and did not show escape from suppression in type of previous episodes, family history, symptoms, or medication. However, those who showed escape tended to respond better to treatment and to be rated as having a more severe depression. The theoretical and clinical implications of these findings are not yet clear.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 426140

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  5 in total

1.  Psychiatry-epitomes of progress: screening for endogenous depression: the dexamethasone suppression test.

Authors:  V I Reus
Journal:  West J Med       Date:  1981-02

Review 2.  [Factors interfering with the dexamethasone suppression test].

Authors:  R Liebl
Journal:  Klin Wochenschr       Date:  1986-06-16

3.  The dexamethasone suppression test in depressive and schizophrenic patients under controlled treatment conditions.

Authors:  H J Möller; W Kissling; P Bottermann
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1986

4.  The dexamethasone suppression test as a predictor of antidepressant response.

Authors:  J D Amsterdam; A Winokur; S Bryant; J Larkin; K Rickels
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

5.  [Dexamethasone suppression test: a biologic marker of endogenous depression?].

Authors:  M Berger; H E Klein
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1984
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.